| Literature DB >> 29299709 |
Hanan Karimah Kiranda1, Rozi Mahmud2, Danmaigoro Abubakar3, Zuki Abubakar Zakaria4,5.
Abstract
The evolution of nanomaterial in science has brought about a growing increase in nanotechnology, biomedicine, and engineering fields. This study was aimed at fabrication and characterization of conjugated gold-cockle shell-derived calcium carbonate nanoparticles (Au-CSCaCO3NPs) for biomedical application. The synthetic technique employed used gold nanoparticle citrate reduction method and a simple precipitation method coupled with mechanical use of a Programmable roller-ball mill. The synthesized conjugated nanomaterial was characterized for its physicochemical properties using transmission electron microscope (TEM), field emission scanning electron microscope (FESEM) equipped with energy dispersive X-ray (EDX) and Fourier transform infrared spectroscopy (FTIR). However, the intricacy of cellular mechanisms can prove challenging for nanomaterial like Au-CSCaCO3NPs and thus, the need for cytotoxicity assessment. The obtained spherical-shaped nanoparticles (light-green purplish) have an average diameter size of 35 ± 16 nm, high carbon and oxygen composition. The conjugated nanomaterial, also possesses a unique spectra for aragonite polymorph and carboxylic bond significantly supporting interactions between conjugated nanoparticles. The negative surface charge and spectra absorbance highlighted their stability. The resultant spherical shaped conjugated Au-CSCaCO3NPs could be a great nanomaterial for biomedical applications.Entities:
Keywords: Au-CSCaCO3NPs; Biomedical applications; Calcium carbonate nanoparticles; Characterization; Cytotoxicity; Fabrication and gold nanoparticles
Year: 2018 PMID: 29299709 PMCID: PMC5752660 DOI: 10.1186/s11671-017-2411-3
Source DB: PubMed Journal: Nanoscale Res Lett ISSN: 1556-276X Impact factor: 4.703
Fig. 1TEM (a, b) images of the Au-CSCaCO3NPs characterizing their different size of the nanoparticles
Fig. 2FESEM a FESEM micrograph of the Au-CSCaCO3NPs describing the morphology. b EDX spectra of the Au-CSCaCO3NPs
EDX elemental composition profile of the Au-CSCaCO3NPs
| Spectrum | C | O | Ca | Cu | Au | Total |
|---|---|---|---|---|---|---|
| Spectrum 1 | 58.39 | 12.04 | 0.00 | 21.30 | 8.27 | 100.00 |
| Spectrum 2 | 62.45 | 13.44 | 0.08 | 18.59 | 5.44 | 100.00 |
| Spectrum 3 | 64.30 | 13.19 | 0.00 | 17.51 | 5.00 | 100.00 |
| Spectrum 4 | 69.90 | 14.32 | 0.00 | 15.27 | 0.52 | 100.00 |
| Spectrum 5 | 69.84 | 14.65 | 0.00 | 15.51 | 0.00 | 100.00 |
| Mean ± SD | 64.97 ± 4.95 | 13.53 ± 1.03 | 0.02 ± 0.04 | 17.64 ± 2.47 | 3.84 ± 3.51 | 100.00 |
Fig. 3a Particle size distribution by intensity of the Au-CSCaCO3NPs. b Zeta potential of the Au-CSCaCO3NPs showing the surface charge
Zeta potential of the Au-CSCaCO3NPs, their size distribution by intensity (d nm), and poly dispersity index (PdI) expressed in mean ± standard deviation
| Au-CSCaCO3NPs | |
|---|---|
| Peak 1 | 96.54 |
| Peak 2 | 2.903 |
| Peak 3 | 0.000 |
| Z-Average (d nm) | 57.97 |
| PdI | 0.4 |
| Zeta Potential (mV) ± SD | − 16.40 ± 3.81 |
Fig. 4Fourier transform infrared spectrometer spectrum of the main characteristic peaks of Au-CSCaCO3NPs. All marks correspond to the frequencies discussed in the text
Fig. 5Uv-Vis spectrophotometer absorbance spectrum of the Au-CSCaCO3NPs as discussed in the text
Fig. 6Cytotoxicity assessment of the MCF-7 and NIH3T3 treated Au-CSCaCO3NPs cells using MTT assay giving percentage cell viability